Ad is loading...
APTO
Price
$0.24
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
LCTX
Price
$0.50
Change
-$0.10 (-16.67%)
Updated
Nov 22 closing price
103 days until earnings call
Ad is loading...

APTO vs LCTX

Header iconAPTO vs LCTX Comparison
Open Charts APTO vs LCTXBanner chart's image
Aptose Biosciences
Price$0.24
Change-$0.00 (-0.00%)
Volume$806.45K
CapitalizationN/A
Lineage Cell Therapeutics
Price$0.50
Change-$0.10 (-16.67%)
Volume$15.61M
CapitalizationN/A
APTO vs LCTX Comparison Chart
Loading...
APTO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
APTO vs. LCTX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTO is a Hold and LCTX is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (APTO: $0.19 vs. LCTX: $0.50)
Brand notoriety: APTO and LCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APTO: 3184% vs. LCTX: 1490%
Market capitalization -- APTO: $3.77M vs. LCTX: $115.05M
APTO [@Biotechnology] is valued at $3.77M. LCTX’s [@Biotechnology] market capitalization is $115.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTO’s FA Score shows that 0 FA rating(s) are green whileLCTX’s FA Score has 0 green FA rating(s).

  • APTO’s FA Score: 0 green, 5 red.
  • LCTX’s FA Score: 0 green, 5 red.
According to our system of comparison, LCTX is a better buy in the long-term than APTO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTO’s TA Score shows that 5 TA indicator(s) are bullish while LCTX’s TA Score has 5 bullish TA indicator(s).

  • APTO’s TA Score: 5 bullish, 5 bearish.
  • LCTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both APTO and LCTX are a good buy in the short-term.

Price Growth

APTO (@Biotechnology) experienced а -47.94% price change this week, while LCTX (@Biotechnology) price change was -41.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

APTO is expected to report earnings on Aug 10, 2023.

LCTX is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LCTX($115M) has a higher market cap than APTO($3.77M). LCTX YTD gains are higher at: -53.771 vs. APTO (-92.520). LCTX has higher annual earnings (EBITDA): -22.1M vs. APTO (-35.78M). LCTX has more cash in the bank: 32.7M vs. APTO (8.33M). LCTX has less debt than APTO: LCTX (2.75M) vs APTO (10.7M). LCTX has higher revenues than APTO: LCTX (8.72M) vs APTO (0).
APTOLCTXAPTO / LCTX
Capitalization3.77M115M3%
EBITDA-35.78M-22.1M162%
Gain YTD-92.520-53.771172%
P/E RatioN/AN/A-
Revenue08.72M-
Total Cash8.33M32.7M25%
Total Debt10.7M2.75M389%
FUNDAMENTALS RATINGS
APTO vs LCTX: Fundamental Ratings
APTO
LCTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
9692
P/E GROWTH RATING
1..100
10074
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (37) in the null industry is somewhat better than the same rating for APTO (90) in the Biotechnology industry. This means that LCTX’s stock grew somewhat faster than APTO’s over the last 12 months.

LCTX's Profit vs Risk Rating (100) in the null industry is in the same range as APTO (100) in the Biotechnology industry. This means that LCTX’s stock grew similarly to APTO’s over the last 12 months.

LCTX's SMR Rating (95) in the null industry is in the same range as APTO (100) in the Biotechnology industry. This means that LCTX’s stock grew similarly to APTO’s over the last 12 months.

LCTX's Price Growth Rating (92) in the null industry is in the same range as APTO (96) in the Biotechnology industry. This means that LCTX’s stock grew similarly to APTO’s over the last 12 months.

LCTX's P/E Growth Rating (74) in the null industry is in the same range as APTO (100) in the Biotechnology industry. This means that LCTX’s stock grew similarly to APTO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APTOLCTX
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 25 days ago
80%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
APTO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BSENF0.07N/A
+3.10%
BASELODE ENERGY CORP.
IMBBY31.760.15
+0.47%
Imperial Brands PLC
CFRUY13.250.02
+0.15%
Compagnie Financiere Richemont AG
NDEKY15.600.01
+0.06%
Nitto Denko Corp.
PEYUF12.24-0.02
-0.16%
Peyto Exploration & Development Corp

APTO and

Correlation & Price change

A.I.dvisor tells us that APTO and BDTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTO and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTO
1D Price
Change %
APTO100%
-22.13%
BDTX - APTO
30%
Poorly correlated
+4.53%
LOGC - APTO
28%
Poorly correlated
+2.01%
MDGL - APTO
28%
Poorly correlated
+5.53%
SLNO - APTO
28%
Poorly correlated
+5.77%
INBX - APTO
26%
Poorly correlated
+0.72%
More

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
-16.02%
MDGL - LCTX
43%
Loosely correlated
+5.53%
APTO - LCTX
36%
Loosely correlated
-22.13%
GBIO - LCTX
34%
Loosely correlated
+3.79%
AXON - LCTX
33%
Loosely correlated
+0.90%
MGTX - LCTX
32%
Poorly correlated
+0.17%
More